NCT02223078View on ClinicalTrials.gov

Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer.

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2000

Primary Completion Date

August 31, 2001

Study Completion Date

November 30, 2001

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

G17DT

BIOLOGICAL

Placebo Comparator

Trial Locations (1)

Unknown

University Hospital Aintree, Liverpool

Sponsors
All Listed Sponsors
lead

Cancer Advances Inc.

INDUSTRY

NCT02223078 - Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer. | Biotech Hunter | Biotech Hunter